Cargando...
Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia
Despite advances in the understanding of disease pathobiology, treatment for relapsed or refractory acute myeloid leukemia (R/R AML) remains challenging. The prognosis of R/R AML remains extremely poor despite chemotherapy and bone marrow transplants. Discoveries on recurrent and novel genetic mutat...
Gardado en:
| Publicado en: | Bosn J Basic Med Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292864/ https://ncbi.nlm.nih.gov/pubmed/33577442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2020.5485 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|